Latest Insider Transactions at Zynex Inc (ZYXI)
This section provides a real-time view of insider transactions for Zynex Inc (ZYXI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ZYNEX INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ZYNEX INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Other acquisition or disposition
|
Indirect |
203,401
-7.91%
|
-
|
|
Nov 05
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
2,969
+4.82%
|
-
|
|
Nov 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.56%
|
$1,742
$13.57 P/Share
|
|
Nov 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,157
+4.06%
|
-
|
|
Nov 04
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
162
-0.68%
|
$2,106
$13.46 P/Share
|
|
Oct 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-7.27%
|
$5,600
$14.24 P/Share
|
|
Oct 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+8.25%
|
-
|
|
Oct 08
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,000
-4.14%
|
$19,000
$19.1 P/Share
|
|
Sep 08
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
800
-3.66%
|
$12,000
$15.76 P/Share
|
|
Sep 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.85%
|
-
|
|
Aug 27
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Other acquisition or disposition
|
Indirect |
11,386,450
-89.78%
|
-
|
|
Aug 27
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
BUY
Other acquisition or disposition
|
Direct |
11,386,450
+45.22%
|
-
|
|
Aug 05
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+5.68%
|
-
|
|
Aug 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
3,376
+3.41%
|
-
|
|
Aug 04
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.83%
|
$2,898
$18.05 P/Share
|
|
Jul 30
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,733
+12.57%
|
$49,194
$18.11 P/Share
|
|
Jul 29
2020
|
Joshua R. Disbrow |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+34.29%
|
-
|
|
Jul 29
2020
|
Barry D Michaels |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.43%
|
-
|
|
Jul 29
2020
|
Michael D Cress |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+36.43%
|
-
|
|
Jul 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,399
-31.99%
|
$50,379
$21.43 P/Share
|
|
Jul 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+9.3%
|
-
|
|
Jul 14
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
1,250,000
-8.97%
|
$27,500,000
$22.0 P/Share
|
|
Jul 08
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,000
-5.79%
|
$21,000
$21.43 P/Share
|
|
Jun 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,482
-9.48%
|
$31,122
$21.43 P/Share
|
|
Jun 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.96%
|
-
|
|
May 20
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+10.87%
|
-
|
|
May 04
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,750
-26.09%
|
$67,500
$18.99 P/Share
|
|
May 04
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,021
+4.02%
|
-
|
|
Apr 30
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-30.88%
|
$510,000
$17.33 P/Share
|
|
Apr 29
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
50,000
-0.36%
|
$850,000
$17.1 P/Share
|
|
Apr 28
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
19,817
-0.14%
|
$317,072
$16.1 P/Share
|
|
Apr 27
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
30,183
-0.22%
|
$482,928
$16.11 P/Share
|
|
Apr 24
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
25,143
-0.18%
|
$377,145
$15.1 P/Share
|
|
Apr 22
2020
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+10.0%
|
-
|
|
Mar 06
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-19.7%
|
$280,000
$14.38 P/Share
|
|
Mar 05
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
24,857
-0.18%
|
$372,855
$15.11 P/Share
|
|
Mar 05
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+5.0%
|
-
|
|
Mar 03
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+48.19%
|
$0
$0.4 P/Share
|
|
Mar 03
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
4,211
-0.03%
|
$58,954
$14.14 P/Share
|
|
Mar 02
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
40,068
-0.28%
|
$560,952
$14.12 P/Share
|
|
Feb 24
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
101,271
-0.24%
|
$1,316,523
$13.6 P/Share
|
|
Jan 08
2020
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+35.09%
|
-
|
|
Jan 08
2020
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Dec 05
2019
|
Daniel J Moorhead CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+10.26%
|
-
|
|
Oct 22
2019
|
Giuseppe Papandrea COO - Zynex Medical, Inc. |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+12.5%
|
-
|
|
Oct 16
2019
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
203,571
+1.21%
|
$0
$0.14 P/Share
|
|
Oct 07
2019
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
12,770
-0.04%
|
$153,240
$12.85 P/Share
|
|
Oct 04
2019
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
91,680
-0.32%
|
$1,100,160
$12.35 P/Share
|
|
Oct 03
2019
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
50,000
-0.35%
|
$550,000
$11.61 P/Share
|
|
Oct 02
2019
|
Thomas Sandgaard PRESIDENT, CEO AND CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
18,740
-0.13%
|
$206,140
$11.11 P/Share
|